olutasidenib

Rigel’s Rezlidhia (olutasidenib) Gets FDA Approval for Relapsed or Refractory AML
Xtalks
Wed, 12/7/22 - 09:53 am
Rigel Pharmaceuticals
Rezlidhia
olutasidenib
FDA
AML
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA
Fierce Biotech
Tue, 08/2/22 - 11:30 pm
Rigel Pharmaceuticals
Forma Therapeutics
olutasidenib
leukemia
FDA